SynthesisThe Cochrane database of systematic reviews2014

Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.

Lorenzo Moja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.